A detailed history of Korea Investment Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Korea Investment Corp holds 1,266,049 shares of ABT stock, worth $148 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
1,266,049
Previous 1,224,862 3.36%
Holding current value
$148 Million
Previous $127 Million 13.41%
% of portfolio
0.35%
Previous 0.33%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $4.12 Million - $4.87 Million
41,187 Added 3.36%
1,266,049 $144 Million
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $22.9 Million - $25.6 Million
-227,563 Reduced 15.67%
1,224,862 $127 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $6.38 Million - $7.04 Million
-58,224 Reduced 3.85%
1,452,425 $165 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $2.64 Million - $3.23 Million
29,296 Added 1.98%
1,510,649 $166 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $8.98 Million - $10.8 Million
-94,000 Reduced 5.97%
1,481,353 $143 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $7.49 Million - $8.35 Million
-74,334 Reduced 4.51%
1,575,353 $172 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $9.78 Million - $11.5 Million
100,975 Added 6.52%
1,649,687 $167 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $8.88 Million - $10.4 Million
-93,433 Reduced 5.69%
1,548,712 $170 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $3.28 Million - $3.8 Million
33,901 Added 2.11%
1,642,145 $159 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $9.11 Million - $11 Million
89,255 Added 5.88%
1,608,244 $175 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $17.9 Million - $21.8 Million
157,107 Added 11.54%
1,518,989 $180 Million
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $39.6 Million - $48.5 Million
342,735 Added 33.63%
1,361,882 $192 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $14.6 Million - $16.1 Million
-124,728 Reduced 10.9%
1,019,147 $120 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $12.5 Million - $14.7 Million
117,849 Added 11.49%
1,143,875 $133 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $18.8 Million - $22.1 Million
-172,301 Reduced 14.38%
1,026,026 $123 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $4.38 Million - $4.77 Million
41,691 Added 3.6%
1,198,327 $131 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $1.21 Million - $1.47 Million
13,200 Added 1.15%
1,156,636 $126 Million
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $2.27 Million - $2.9 Million
29,600 Added 2.66%
1,143,436 $105 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $14.2 Million - $20.7 Million
-225,300 Reduced 16.82%
1,113,836 $87.9 Million
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $5.1 Million - $5.67 Million
64,900 Added 5.09%
1,339,136 $116 Million
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $2.25 Million - $2.44 Million
-27,500 Reduced 2.11%
1,274,236 $107 Million
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $4.11 Million - $4.79 Million
56,400 Added 4.53%
1,301,736 $109 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $1.45 Million - $1.76 Million
21,950 Added 1.79%
1,245,336 $99.6 Million
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $419,584 - $475,328
-6,400 Reduced 0.52%
1,223,386 $88.5 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $8.97 Million - $10.8 Million
-147,525 Reduced 10.71%
1,229,786 $90.2 Million
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $2.37 Million - $2.61 Million
41,100 Added 3.08%
1,377,311 $0
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $172,411 - $194,931
-3,064 Reduced 0.23%
1,336,211 $80.1 Million
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $21.2 Million - $22.7 Million
395,000 Added 41.83%
1,339,275 $76.4 Million
Q3 2017

Oct 25, 2017

BUY
$48.06 - $53.64 $45.4 Million - $50.7 Million
944,275
944,275 $50.4 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.